Test Price
2,500 AED✅ Home Collection Available
Interferon‑Beta IgG Antibody (MAID) Test – Dubai, UAE | DNA Labs UAE
Executive Summary & Core Metrics
Clinical Accuracy: 99.9% diagnostic sensitivity via ISO 9001:2015 accredited multianalyte immunodetection (MAID) for binding IgG antibodies against interferon‑beta.
Premium Logistics: VIP Mobile Phlebotomy & Temperature‑Controlled Cold‑Chain Home Collection available daily from 8 AM to 11 PM. Includes paid hospital‑grade transport.
Price: 2,500 AED inclusive of collection, laboratory processing, and telephonic post‑test clinical guidance by a DHA‑licensed general practitioner.
Insurance: Direct billing verification via WhatsApp +971 54 548 8731.
Clinical Guidance: Telephonic interpretation session included with every result. Reports delivered within 2–3 weeks after monthly batch cut‑off on the 7th.
Test Overview & Methodology
This quantitative assay detects and measures IgG antibodies directed against interferon‑beta using fully automated multianalyte immunodetection (MAID). The test is indicated for patients with multiple sclerosis receiving interferon‑beta therapies (Avonex, Rebif, Betaseron) to evaluate treatment response and identify loss of efficacy due to binding antibody formation. Results assist the neurologist in making informed therapy modification decisions.
| Feature | Our Test (MAID) | Closest Alternative (ELISA) |
|---|---|---|
| Precision / Method | Multianalyte Immunodetection – fully automated, high‑avidity IgG detection | Standard colorimetric ELISA |
| Clinical Sensitivity | ≥99.9% for binding antibodies | ~95% (may miss low‑titer samples) |
| Turnaround Time | 2–3 weeks (batch processing, sample cut‑off on the 7th of each month) | 5–7 working days |
| Regulatory Status | ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139), DHA‑licensed facility | Local lab accreditation only |
| Price (AED) | 2,500 | 1,800 |
Physician Insight & Safety Protocols
“Test results for interferon‑beta IgG antibodies must be interpreted alongside clinical disease activity, MRI findings, and the patient’s treatment history. A negative antibody test does not definitively exclude the presence of neutralizing antibodies. Therapy adjustments should never be made based solely on this assay without comprehensive neurological evaluation.”
— Dr. Ajay Singh, General Practitioner | DHA Registration ID: 36234132
Medication Safety Advisory
Do not discontinue prescribed interferon‑beta therapy without consulting your treating neurologist. Abrupt withdrawal can provoke disease reactivation, relapse, or rebound neurological deterioration. Always adhere to your prescribed dosing schedule unless otherwise directed by your physician.
Patient Exclusion Criteria & Emergency Red Flags
Pre‑collection Exclusion Criteria
- Active systemic infection or febrile illness – temporary exclusion until resolution.
- Known hypersensitivity to any component of the collection kit or latex.
- Current use of other immunomodulatory biologics (e.g., natalizumab, ocrelizumab) – may interfere with interpretation; discuss with your neurologist before testing.
- Pregnancy – relative contraindication; testing may be deferred until postpartum unless clinically urgent.
- Severe needle phobia with history of vasovagal syncope – request medical‑supervised collection at a DHA facility.
Emergency Red Flags – Seek Immediate Medical Attention
- Sudden onset of hives, facial swelling, or difficulty breathing after interferon injection.
- New neurological deficit (vision loss, limb weakness, bladder dysfunction) within 24 hours of sample collection.
- Signs of anaphylaxis: rapid pulse, dizziness, loss of consciousness.
Patient FAQ & Clinical Guidance
1. What is the purpose of this test?
This test quantifies IgG binding antibodies to interferon‑beta to identify patients who may have developed reduced drug efficacy. It aids neurologists in determining whether a therapy switch is warranted based on objective laboratory evidence.
2. How should I prepare for the blood collection?
Collect your sample at least 8 hours after your interferon injection. Inform the phlebotomist of your current medication, dose, and therapy duration. Complete Form 35 (Test Send‑Out Consent Form) and keep the sample refrigerated until pickup.
Pre‑test checklist: Provide details of Avonex, Rebif, or Betaseron; ensure sample is collected after the 8‑hour post‑injection window.
3. When will I receive my report, and who interprets the results?
Reports are delivered within 2–3 weeks after the monthly batch cut‑off on the 7th. A telephonic post‑test clinical guidance session with a DHA‑licensed general practitioner is included to explain your results and answer any follow‑up questions.
4. Can I have the test done at home?
Yes – VIP Mobile Phlebotomy & Temperature‑Controlled Cold‑Chain Home Collection is available daily from 8 AM to 11 PM. A certified phlebotomist will visit your residence, collect the specimen under sterile conditions, and transport it to our ISO‑accredited laboratory under strict cold‑chain integrity.
UAE Regulatory & Data Privacy Adherence
Regulatory & Quality Compliance Framework
All procedures strictly adhere to Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical safety and patient consent are governed by Federal Decree‑Law No. 4 of 2016 on Medical Liability. The laboratory operates under ISO 9001:2015 certification (Cert: INT/EGQ/2509DA/3139) and is licensed by the Dubai Health Authority (DHA Facility License No: 1143). Home collection logistics maintain full cold‑chain integrity and comply with UAE health transport regulations.
Clinical & Logistical Metadata
| Test Name | Interferon‑Beta IgG Antibody (MAID) Test |
| Price (AED) | 2,500 |
| Turnaround Time | 2–3 weeks (batch processing; sample cut‑off on the 7th of each month) |
| Sample Type / Matrix | Serum (peripheral venous blood) – VIP Mobile Phlebotomy & Cold‑Chain Home Collection available |
| Methodology Used | Multianalyte Immunodetection (MAID) – fully automated, high‑avidity IgG detection |
| ICD-10-CM Code | G35 |
| LOINC Code | 93921-2 |
| DHA Facility License & Laboratory Address | DHA License: 1143 | DNA Labs UAE, Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians